Contact information
Research groups
Recent publications
-
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
Dold C. et al, (2025), Science Translational Medicine, 17
-
The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial.
Saso A. et al, (2025), Lancet Infect Dis
-
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol.
Brito-Mutunayagam S. et al, (2025), PLoS One, 20
Kiarash Tanha
MSc
Medical Statistician
In 2022, I joined the Oxford Vaccine Group as a Medical Statistician, following four years of conducting collaborative research projects and utilising statistical analyses in RCTs.
Currently, I help design, set up, analyse and disseminate various vaccine trials, including COV-Boost, PERISCOPE, SALVO, RESPECCT, and RATIONALE.
I was awarded an NIHR pre-doctoral fellowship in 2023, where I investigated the application of novel designs in controlled human infection model (CHIM) vaccine trials, utilising historical data.
My research interests primarily focus on developing efficient trial designs and implementing them effectively in clinical trials.
There was an error while rendering this tile